Dr. Martinez-Outshoorn

Ubaldo Martinez-Outshoorn, MD

Contact Dr. Martinez-Outshoorn

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes
  2. Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
  3. MCT1 in invasive ductal carcinoma: Monocarboxylate metabolism and aggressive breast cancer
  4. Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization
  5. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity
  6. EBV-associated peripheral t-cell lymphoma of gastrointestinal tract presented with widespread chronic inflammation: A case report
  7. TP53-inducible glycolysis and apoptosis regulator (TIGAR) metabolically reprograms carcinoma and stromal cells in breast cancer
  8. Multicompartment metabolism in papillary thyroid cancer
  9. Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
  10. Cancer stem cell metabolism
  11. Cancer metabolism: a therapeutic perspective
  12. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  13. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
  14. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  15. Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
  16. A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
  17. Caveolae and signalling in cancer
  18. Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?
  19. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
  20. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells